Your browser doesn't support javascript.
loading
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.
Nielsen, Carolyn M; Barrett, Jordan R; Davis, Christine; Fallon, Jonathan K; Goh, Cyndi; Michell, Ashlin R; Griffin, Catherine; Kwok, Andrew; Loos, Carolin; Darko, Samuel; Laboune, Farida; Tekman, Mehmet; Diouf, Ababacar; Miura, Kazutoyo; Francica, Joseph R; Ransier, Amy; Long, Carole A; Silk, Sarah E; Payne, Ruth O; Minassian, Angela M; Lauffenburger, Douglas A; Seder, Robert A; Douek, Daniel C; Alter, Galit; Draper, Simon J.
Afiliação
  • Nielsen CM; University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Barrett JR; University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Davis C; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.
  • Fallon JK; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA.
  • Goh C; University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Michell AR; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA.
  • Griffin C; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.
  • Kwok A; University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Loos C; Wellcome Center for Human Genetics, University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Darko S; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.
  • Laboune F; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA.
  • Tekman M; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.
  • Diouf A; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.
  • Miura K; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Francica JR; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.
  • Ransier A; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.
  • Long CA; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.
  • Silk SE; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.
  • Payne RO; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.
  • Minassian AM; University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Lauffenburger DA; University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Seder RA; University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Douek DC; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.
  • Alter G; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.
  • Draper SJ; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA.
JCI Insight ; 8(2)2023 Jan 24.
Article em En | MEDLINE | ID: mdl-36692019
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Antimaláricas Limite: Humans Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Antimaláricas Limite: Humans Idioma: En Revista: JCI Insight Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido